--- title: "Wesfarmers (ASX:WES) Valuation In Focus As Inflation Data And Upcoming Results Draw Investor Attention" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/271936420.md" description: "Wesfarmers (ASX:WES) is under scrutiny as inflation data and upcoming results may impact interest rates and consumer spending, affecting its Bunnings and Kmart businesses. Currently priced at A$80.96, it has a 90-day return of 9.07% but a slightly negative year-to-date performance. Analysts project earnings of A$3.5 billion by September 2028, with a fair value estimate of A$80.82, indicating it may be overvalued. Investors are advised to consider risks related to cost inflation and the success of new ventures in healthcare and lithium." datetime: "2026-01-08T13:00:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/271936420.md) - [en](https://longbridge.com/en/news/271936420.md) - [zh-HK](https://longbridge.com/zh-HK/news/271936420.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/271936420.md) | [English](https://longbridge.com/en/news/271936420.md) # Wesfarmers (ASX:WES) Valuation In Focus As Inflation Data And Upcoming Results Draw Investor Attention Wesfarmers (ASX:WES) is back in focus as traders watch key inflation data that could influence interest rate expectations and consumer spending, two forces closely tied to its core Bunnings and Kmart businesses. See our latest analysis for Wesfarmers. At a share price of A$80.96, Wesfarmers has seen some pressure recently, with a 90 day share price return of 9.07% and a slightly negative year to date move. Its 1 year total shareholder return of 15.9% and 5 year total shareholder return of 97.02% point to momentum that has been stronger over the longer term, while investors now weigh higher inflation risks against the company’s past investments in technology, AI and growth areas such as healthcare and lithium. If inflation and rate expectations have you reassessing retail exposure, it can help to widen the lens and look at fast growing stocks with high insider ownership as potential alternatives worth investigating next. With Wesfarmers trading around A$80.96, close to its A$80.82 analyst price target and with an intrinsic value estimate sitting slightly below the market, the key question is whether there is still a buying opportunity here or if future growth is already priced in. ## Most Popular Narrative: 0.2% Overvalued With Wesfarmers last closing at A$80.96 against a narrative fair value of about A$80.82, the story hinges on steady but not explosive growth and what investors are prepared to pay for it. > _Analysts expect earnings to reach A$3.5 billion (and earnings per share of A$3.05) by about September 2028, up from A$2.9 billion today. The analysts are largely in agreement about this estimate._ Read the complete narrative. Curious how mid single digit growth, firm margins and a premium future P/E are all stitched together into that A$80 plus fair value? The narrative leans on detailed revenue forecasts, a tight earnings range and a specific discount rate to justify today’s valuation. Want to see exactly how those moving parts line up, and what has to go right for the numbers to hold? **Result: Fair Value of A$80.82 (OVERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, this hinges on cost inflation staying manageable and new ventures like healthcare and lithium scaling as planned, with any stumble quickly challenging today’s A$80-plus story. Find out about the key risks to this Wesfarmers narrative. ## Build Your Own Wesfarmers Narrative If you see the story differently or prefer to test the numbers yourself, you can create your own version in a few minutes by using Do it your way. A great starting point for your Wesfarmers research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision. ## Looking for more investment ideas? If Wesfarmers is on your radar, do not stop there. Broaden your watchlist with focused stock ideas that match how you like to invest and manage risk. - Spot potential value gaps by checking out these 886 undervalued stocks based on cash flows that may be pricing in more caution than their cash flows suggest. - Tap into high growth themes by scanning these 26 AI penny stocks that are tied to real businesses rather than hype alone. - Strengthen your income focus by reviewing these 12 dividend stocks with yields \> 3% that could complement holdings like Wesfarmers in a diversified portfolio. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ## 相關資訊與研究 - [There’s Been A Staggering Number Of Deaths In ICE Custody During Trump’s Second Term](https://longbridge.com/zh-HK/news/281293924.md) - [Citi Keeps Their Sell Rating on Treasury Wine Estates Limited (TSRYF)](https://longbridge.com/zh-HK/news/281265561.md) - [Citi Sticks to Their Buy Rating for Qantas Airways Limited (QUBSF)](https://longbridge.com/zh-HK/news/281103708.md) - [ZAWYA: Cambridge Health Group announces 70 bed expansion of Cambridge Hospital Jeddah](https://longbridge.com/zh-HK/news/281484041.md) - [01:40 ETVARON Marks Earth Hour 2026 with a Call for Sustainable Respiratory Care and Climate Action](https://longbridge.com/zh-HK/news/281607445.md)